PCORI Awards $150 Million for Patient-Centered Research
These awards cover research on a variety of crucial health areas including asthma, heart failure, migraine prevention and more.
The Patient-Centered Outcomes Research Institute (PCORI) has awarded over $150 million in funding for new patient-centered comparative clinical effectiveness research (CER) studies. These initiatives cover a variety of crucial health areas including asthma, heart failure, migraine prevention and more.
Nine awards for patient-centered CER have been granted, with two large-scale trials focusing on heart failure and asthma treatments.
In addition, PCORI awarded funds to enhance CER methodologies and gather evidence on how to improve patient engagement in research.
These investments reflect the growing prevalence of patient-centered research in reshaping clinical approaches, as shared in a report by IQVIA.
Reshaping clinical approaches, according to the report, includes building trust and being open in the relationship between patients and researchers.
When patients are included in every part of the research, from planning to analyzing, it creates a sense of respect on both sides. This not only keeps people engaged but also supplies researchers with crucial data.
Showcasing a wide range of data sources, patient-centered research goes beyond traditional clinical outcomes to include the experiences and preferences of patients, according to the report.
In return, this approach results in the credibility of research findings.
As patient-centered research continues to grow, it marks a significant shift in healthcare toward a model where the patient's perspective supports scientific exploration and ensures that research outcomes benefit who they are meant to.
“As a leading funder of patient-centered comparative clinical effectiveness research, PCORI recognizes the evidence generated from PCORI-funded research helps patients and those who care for them make informed decisions about which health care options will work best for them," PCORI executive sirector Nakela L. Cook, M.D., MPH, said in the release.
Trust, transparency and the utilization of high-quality data is crucial to develop deeper insights and more impactful healthcare solutions.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
